Official Title
Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19
Brief Summary

Describes the cohort of patients receiving ECMO-VV or ECMO-VA in the management of severe ARDS refractory to SARS-CoV-2 in the Strasbourg and Louvain centres

Status
Completed
Conditions
COVID-19
Eligibility Criteria

Inclusion Criteria:

- Patient over the age of 18;

- Diagnostic COVID-19 by RT-PCR;

- Hospitalisation in resuscitation for the management of complications related to
COVID-19

- Implanted ECMO-VV or VA during hospitalisation;

- Patient agreeing to participate in the study

Exclusion Criteria:

- Sujet who has expressed opposition to participating in the study.

- Sujet under guardianship or trusteeship

- Sujet under safeguard of justice

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Universitaires de Strasbourg
Strasbourg, France

Sponsors / Collaborators
University Hospital, Strasbourg, France
NCT Number
NCT04446286
Keywords
Respiratory Distress Syndrome
SARS-CoV-2
Extracorporeal membrane oxygenation
ECMO-VV
ECMO-VA
Veno-venous ECMO
MeSH Terms
COVID-19